Cargando…
Beyond glucose: alternative sources of energy in glioblastoma
Glioblastoma multiforme (GBM) is the most common malignant brain tumor in adults. With a designation of WHO Grade IV, it is also the most lethal primary brain tumor with a median survival of just 15 months. This is often despite aggressive treatment that includes surgical resection, radiation therap...
Autores principales: | Caniglia, John L., Jalasutram, Anvesh, Asuthkar, Swapna, Sahagun, Joseph, Park, Simon, Ravindra, Aditya, Tsung, Andrew J., Guda, Maheedhara R., Velpula, Kiran K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797684/ https://www.ncbi.nlm.nih.gov/pubmed/33500708 http://dx.doi.org/10.7150/thno.53506 |
Ejemplares similares
-
Immunopathology of galectin-3: an increasingly promising target in COVID-19
por: Caniglia, John L., et al.
Publicado: (2020) -
A potential role for Galectin-3 inhibitors in the treatment of COVID-19
por: Caniglia, John L., et al.
Publicado: (2020) -
Targeting RGS4 Ablates Glioblastoma Proliferation
por: Guda, Maheedhara R., et al.
Publicado: (2020) -
Galectin-1 activates carbonic anhydrase IX and modulates glioma metabolism
por: Guda, Maheedhara R., et al.
Publicado: (2022) -
GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets
por: Guda, Maheedhara R., et al.
Publicado: (2019)